Dr. Nabil Noureddin (Medicine) recently published a manuscript, “Driving NASH Forward Using the FAST Score but Obey the Traffic Lights,” in Hepatology Journal. He is the first author on the paper that commented on a recent study that developed a non-invasive score to identify patients at risk of progressive nonalcoholic steatohepatitis (NASH) — a condition that affects around 16.52 million Americans. Noureddin and his co-authors proposed a new approach to address the shortfall in the new score so it can be better utilized widely.